Clinical Trial Update: Safety and Efficacy Study of LAmbre LAA Closure Device for Treating AF Patients Who Cannot Take Warfarin [Phase 3]

View source ↗

Summary

This clinical trial update reports on a Phase 3 study evaluating the LAmbre LAA closure device for atrial fibrillation patients who cannot take warfarin, focusi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• LAmbre LAA closure device

Snippet

Sponsor: Lifetech Scientific (Shenzhen) Co., Ltd. | Conditions: Atrial Fibrillation | Phase 3 | Status: UNKNOWN